Ethnic Differences in Cardiovascular Risks and Mortality in Atherothrombotic Disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Overview

Journal Mayo Clin Proc

Specialty General Medicine

Date 2011 Oct 4

PMID 21964173

Citations 48

Authors

Telly A Meadows

Deepak L Bhatt

Christopher P Cannon

Bernard J Gersh

Joachim Rother

Shinya Goto

Chiau-Suong Liau

Peter W F Wilson

Genevieve Salette

Sidney C Smith

Ph Gabriel Steg

Affiliations

Soon will be listed here.

Abstract

Objective: To determine whether ethnic-specific differences in the prevalence of cardiovascular risk factors and outcomes exist worldwide among individuals with stable arterial disease.

Patients And Methods: From December 1, 2003, to June 30, 2004, the prospective, observational REduction of Atherothrombosis for Continued Health (REACH) Registry enrolled 49,602 out-patients with coronary artery disease, cerebrovascular disease, and/or peripheral arterial disease from 7 predefined ethnic/racial groups: white, Hispanic, East Asian, South Asian, Other Asian, black, and Other (comprising any race distinct from those specified). The baseline demographic and risk factor profiles, medication use, and 2-year cardiovascular outcomes were assessed among these groups.

Results: The prevalence of traditional atherothrombotic risk factors varied significantly among the ethnic/racial groups. The use of medical therapies to reduce risk was comparable among all groups. At 2-year follow-up, the rate of cardiovascular death was significantly higher in blacks (6.1%) compared with all other ethnic/racial groups (3.9%; P=.01). Cardiovascular death rates were significantly lower in all 3 Asian ethnic/racial groups (overall, 2.1%) compared with the other groups (4.5%; P<.001).

Conclusion: The REACH Registry, a large international study of individuals with atherothrombotic disease, documents the important ethnic-specific differences in cardiovascular risk factors and variations in cardiovascular mortality that currently exist worldwide.

Citing Articles

Patient Demographics and Major Adverse Cardiovascular Events after Androgen Deprivation Therapy for Prostate Cancer.

Wallis C, Chen K, Atkinson S, Boldt-Houle D Adv Urol. 2024; 2024:2988289.

PMID: 39372193 PMC: 11452244. DOI: 10.1155/2024/2988289.

Characterization of the literature informing health care of transgender and gender-diverse persons: A bibliometric analysis.

Pattar B, Gulamhusein N, Rytz C, Turino Miranda K, Beach L, Marshall Z PLoS One. 2024; 19(10):e0309169.

PMID: 39365757 PMC: 11452042. DOI: 10.1371/journal.pone.0309169.

Racial and Socioeconomic Determinants of Cardiovascular Health: A Comprehensive Review.

Borkowski P, Borkowska N, Mangeshkar S, Adal B, Singh N Cureus. 2024; 16(5):e59497.

PMID: 38826910 PMC: 11143437. DOI: 10.7759/cureus.59497.

Questionable Effects of Electronic Cigarette Use on Cardiovascular Diseases From the National Health Interview Survey (NHIS, 2014-2021).

Plurphanswat N, Selya A, Rodu B Cureus. 2024; 16(3):e57119.

PMID: 38681373 PMC: 11055619. DOI: 10.7759/cureus.57119.

Benefits of statin therapy within a year after kidney transplantation.

Yim S, Kim H, Ro H, Ryu J, Kim M, Park J Sci Rep. 2024; 14(1):2002.

PMID: 38263253 PMC: 10805738. DOI: 10.1038/s41598-024-52513-6.

References

Lillie-Blanton M, Maddox T, Rushing O, Mensah G . Disparities in cardiac care: rising to the challenge of Healthy People 2010. J Am Coll Cardiol. 2004; 44(3):503-8. DOI: 10.1016/j.jacc.2004.04.043. View

Razak F, Anand S, Vuksan V, Davis B, Jacobs R, Teo K . Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond). 2005; 29(6):656-67. DOI: 10.1038/sj.ijo.0802937. View

Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A . Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008; 371(9616):915-22. DOI: 10.1016/S0140-6736(08)60417-1. View

Morrissey N, Giacovelli J, Egorova N, Gelijns A, Moskowitz A, McKinsey J . Disparities in the treatment and outcomes of vascular disease in Hispanic patients. J Vasc Surg. 2007; 46(5):971-8. PMC: 2605850. DOI: 10.1016/j.jvs.2007.07.021. View

Yang J, Shiwaku K, Nabika T, Masuda J, Kobayashi S . High frequency of cardiovascular risk factors in overweight adult Japanese subjects. Arch Med Res. 2007; 38(3):337-44. DOI: 10.1016/j.arcmed.2006.10.014. View

Wang J, Thornton J, Burastero S, Shen J, Tanenbaum S, Heymsfield S . Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res. 1996; 4(4):377-84. DOI: 10.1002/j.1550-8528.1996.tb00245.x. View

Chang I, Gelman R, Pagano M . Corrected group prognostic curves and summary statistics. J Chronic Dis. 1982; 35(8):669-74. DOI: 10.1016/0021-9681(82)90019-4. View

Halm E, Tuhrim S, Wang J, Rojas M, Rockman C, Riles T . Racial and ethnic disparities in outcomes and appropriateness of carotid endarterectomy: impact of patient and provider factors. Stroke. 2009; 40(7):2493-501. PMC: 2743296. DOI: 10.1161/STROKEAHA.108.544866. View

Mak K, Bhatt D, Shao M, Hankey G, Easton J, Fox K . Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. Am Heart J. 2009; 157(4):658-65. DOI: 10.1016/j.ahj.2008.08.031. View

10.

Wilson C, Fisher E, Welch H . Racial disparities in abdominal aortic aneurysm repair among male Medicare beneficiaries. Arch Surg. 2008; 143(5):506-10. DOI: 10.1001/archsurg.143.5.506. View

11.

Vaccarino V, Rathore S, Wenger N, Frederick P, Abramson J, Barron H . Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005; 353(7):671-82. PMC: 2805130. DOI: 10.1056/NEJMsa032214. View

12.

Ohman E, Bhatt D, Steg P, Goto S, Hirsch A, Liau C . The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design. Am Heart J. 2006; 151(4):786.e1-10. DOI: 10.1016/j.ahj.2005.11.004. View

13.

Meadows T, Bhatt D, Hirsch A, Creager M, Califf R, Ohman E . Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry. Am Heart J. 2009; 158(6):1038-45. DOI: 10.1016/j.ahj.2009.09.014. View

14.

Steg P, Bhatt D, Wilson P, DAgostino Sr R, Ohman E, Rother J . One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007; 297(11):1197-206. DOI: 10.1001/jama.297.11.1197. View

15.

Bhatt D, Steg P, Ohman E, Hirsch A, Ikeda Y, Mas J . International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006; 295(2):180-9. DOI: 10.1001/jama.295.2.180. View

16.

Ramaraj R, Chellappa P . Cardiovascular risk in South Asians. Postgrad Med J. 2008; 84(996):518-23. DOI: 10.1136/pgmj.2007.066381. View

17.

Kennedy B, Fortmann S, Stafford R . Elective and isolated carotid endarterectomy: health disparities in utilization and outcomes, but not readmission. J Natl Med Assoc. 2007; 99(5):480-8. PMC: 2576064. View

18.

Chen M, Bhatt D, Chew D, Moliterno D, Ellis S, Topol E . Outcomes in African Americans and whites after percutaneous coronary intervention. Am J Med. 2005; 118(9):1019-25. DOI: 10.1016/j.amjmed.2004.12.035. View

19.

Collins T, Petersen N, Suarez-Almazor M, Ashton C . The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 2003; 163(12):1469-74. DOI: 10.1001/archinte.163.12.1469. View

20.

Criqui M, Vargas V, Denenberg J, Ho E, Allison M, Langer R . Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005; 112(17):2703-7. DOI: 10.1161/CIRCULATIONAHA.105.546507. View